The Efficacy of Transdiagnostic Cognitive Behavioral Therapy on Migraine Headache: A Randomized Clinical Trial (P15-2.002)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To investigate the efficacy of transdiagnostic cognitive behavioral therapy (TCBT) on headache and the accompanying symptoms in patients suffering from migraine
Background: Psychological interventions are shown to be effective in migraine, but not utilized routinely yet due to the problems of feasibility and practicability. Specific features of TCBT significantly increase the potential for its utilization as a psychological intervention in the healthcare system. However, no studies have evaluated the efficacy of TCBT on adult population with migraine, hitherto.
Design/Methods: This study was conducted on 40 migraine patients aged 20–50 years. We randomly assigned patients to two groups of intervention, receiving 10 sessions of TCBT, and control. Days with headache, headache severity, migraine-related disability and effects on daily life, number of pain-relivers taken for headache, depression, and anxiety were assessed pre-intervention, post-intervention (three-month follow-up), and one-month after TCBT termination (four-month follow-up).
Results: Thirty-five patients suffering moderate to severe migraine completed the study (16 and 19 in TCBT and control groups, respectively). TCBT improved all measured items between study time-points (p<0.05) in the intervention group, while such an improvement was not observed in the control group. Between group comparisons revealed superiority of TCBT group compared to the control group in most measured items at three- and four-month follow-ups (p<0.05).
Conclusions: Ten sessions of TCBT improved migraine severity, associated disability, anxiety, and depression in patients, with persistent effects after one month of therapy termination. TCBT is an affordable, practical, and feasible intervention to be utilized for migraine patients.
Disclosure: Negin Badihian has nothing to disclose. Mrs. Soleimanian Boroujeni has nothing to disclose. Dr. Badihian has nothing to disclose. Vahid Shaygannejad has nothing to disclose. Dr. Gorji has nothing to disclose.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.